To further characterize gene expression in KIS-1 DLBCL cells we used next-generation sequencing, specifically RNA-seq, to compare this cell line to the RAJI cell line, which has much lower PAX5 expression yet strong expression of both CD19 and CD79b (Fig. 1a). This evidence concerns the gene CD79B and diffuse large B-cell lymphoma.